Sector valuations GlaxoSmithKline Pharmaceuticals Limited
Stocks
500660
INE159A01016
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,358.85 INR | +0.18% |
|
+4.06% | -4.54% |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 34.99x | 15x | 3.48x | - | - | - | 1.25% | 4.23B | ||
| 32.55x | 19.64x | 0.66x | 11.89x | 24.17x | 24.96x | 0.61% | 996B | ||
| 25.76x | 6.49x | -1.7x | 5.93x | 16.13x | 17.84x | 2.21% | 580B | ||
| 29.68x | -855.05x | 0.13x | 6.99x | 14.31x | 14.68x | 2.95% | 415B | ||
| 17.69x | 6.57x | 1.04x | 4.4x | 10.82x | 12.21x | 3.02% | 326B | ||
| 21.2x | 6.36x | 120.64x | 5.48x | 13.29x | 14.52x | 2.92% | 280B | ||
| 22.95x | 5.35x | 1.04x | 4.79x | 13.58x | 14.28x | 1.82% | 284B | ||
| 13.82x | 5.97x | -6.53x | 5.11x | 10.52x | 12.29x | 3.64% | 210B | ||
| 22.85x | 17.04x | 2.83x | 6.11x | 10.67x | 13.99x | 2.87% | 190B | ||
| -44.84x | 8.5x | 0.32x | 5.41x | 29.86x | 60.28x | 2.59% | 155B | ||
| 11.24x | 1.56x | 0.2x | 3x | 7.31x | 8.51x | 7.29% | 137B | ||
| 27.17x | 5.45x | 1.92x | 8.27x | 18.65x | 19.41x | -.--% | 121B | ||
| 10.78x | 4.77x | 0.23x | 2.98x | 7.96x | 8.65x | 4.57% | 112B | ||
| 12.52x | 4.51x | 1.21x | 2.72x | 8.01x | 9.03x | 3.59% | 102B | ||
| 10.94x | 1.18x | 2.17x | 2.1x | 6.78x | 7.7x | 5.79% | 100B | ||
| 24.26x | 5.5x | 1.41x | 8.23x | 15.57x | 16.29x | 1.82% | 76.3B | ||
| 41.55x | 1.08x | 60.71x | 2.59x | 9.51x | 26.34x | 4% | 49.84B | ||
| 35.72x | 4.83x | 1.86x | 7.97x | 26.59x | 29.29x | 0.54% | 48.84B | ||
| 16.82x | 1.38x | -0.1x | 1.55x | 7.35x | 12.33x | 0.58% | 44.18B | ||
| Average | 19.35x | -38.63x | 10.08x | 5.31x | 13.95x | 17.92x | 2.74% | 222.77B | |
| Weighted average by Cap. | 22.01x | -75.00x | 8.80x | 6.87x | 16.15x | 18.62x | 2.36% |
- Stock Market
- Stocks
- 500660 Stock
- Sector GlaxoSmithKline Pharmaceuticals Limited
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















